What is osteoporosis? THE “SILENT THIEF” Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which can lead to increased risk of fracture. Known as […]

ABOUT THE DISEASE What is Osteoporosis? Osteoporosis is a disease that slowly, quietly weakens bones, often going undiagnosed – even when it breaks them. Osteoporosis is caused by low bone […]

Bone Health Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which can lead to increased risk of fracture. Nutrition and exercise can play a […]

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

Bubl Fashion Feb 7th, 2019 Introducing a new collection from fashion designer, David Dixon, working in partnership with Osteoporosis Canada. LEARN MORE Living with the Disease Get valuable insight into […]

Bone Health & Osteoporosis Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which can lead to increased risk of fracture. Nutrition and exercise can […]

Osteoporosis is a disease that takes years to develop without any warning symptoms. Bone mass is gradually lost, making the bones weaker and more prone to fracturing or breaking. The […]

In 2008, Gerry was diagnosed during a screening by his doctor because he had risk factors. Since then, he has managed his osteoporosis and now has low bone mass (osteopenia) and has steered clear of fractures. Although his life hasn’t changed all that much, he volunteers on a regular basis with Osteoporosis Canada. He finds that it helps people to be able to talk to someone who also has osteoporosis.

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]